Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03331562
Title A SU2C Catalyst Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Translational Genomics Research Institute
Indications

pancreatic adenocarcinoma

Therapies

Pembrolizumab

Paricalcitol + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.